Trump/Cook, Nissan weakness, more tariffs and gold - what’s moving markets
In a recent transaction, Geoffrey M. Parker, a director at Perrigo Co . plc (NYSE:PRGO), a healthcare company with a market capitalization of $3.6 billion and a "GOOD" Financial Health score according to InvestingPro, acquired 3,500 ordinary shares of the company. The shares were purchased at $27.10 each, amounting to a total transaction value of $94,850 - slightly above the current trading price of $26.02. While the company wasn’t profitable in the last twelve months, analysts expect positive earnings this year. Following this acquisition, Parker now directly owns 23,762 shares. Additionally, he holds 25,879 shares indirectly through a revocable trust and 5,500 shares through a Roth IRA. Want deeper insights? InvestingPro offers exclusive tips and comprehensive analysis, including detailed Fair Value estimates and growth projections.
In other recent news, Perrigo Company reported its first quarter 2025 earnings, surpassing analyst expectations with an adjusted earnings per share (EPS) of $0.60, compared to the consensus estimate of $0.55. Despite this positive earnings performance, the company experienced a revenue shortfall, posting $1.04 billion against the projected $1.09 billion. The company’s net sales declined by 3.5% year-over-year, influenced by divested businesses, exited product lines, and currency translation. Notably, Perrigo’s adjusted gross margin improved significantly, expanding by 440 basis points to 41.0%, with further operating margin growth attributed to recovery in the infant formula sector and supply chain enhancements.
Jefferies recently adjusted its price target for Perrigo’s stock, lowering it to $30 from $31, while maintaining a Hold rating. This decision followed the company’s financial performance, which showed a 106% surge in EPS despite a 3.5% decrease in revenue. The analyst cited challenges such as consumer uncertainty and tariffs, which have contributed to market volatility. However, Perrigo’s management remains confident in achieving their goals despite these challenges. Jefferies’ Hold rating reflects cautious optimism regarding Perrigo’s operational strategies and the stock’s near-term price performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.